Flumazenil Kabi 0.5mg/5mL Amp 5 (Flumazenil 0.5mg Amp)

Flumazenil Kabi 0.5mg/5mL Amp 5 is a benzodiazepine antagonist, meticulously formulated for the rapid reversal of the sedative effects induced by benzodiazepines. As a specific and selective receptor antagonist, it is an essential agent in anesthesia and emergency medicine, providing a safety net for patients undergoing procedures that require sedation.

Product Specifications:
- Active Ingredient: Flumazenil 0.5mg per 5mL ampoule
- Concentration: 0.1mg/mL
- Volume: 5mL per ampoule
- Packaging: Box of 5 ampoules
- Storage: Store between 2°C to 8°C (Refrigerate, do not freeze)
- Route of Administration: Intravenous

Common Applications:
- Reversal of benzodiazepine-induced sedation in anesthesia and conscious sedation for diagnostic or therapeutic procedures.
- Management of benzodiazepine overdose in emergency settings.
- Diagnostic tool for suspected benzodiazepine-related neurological impairment.

User Groups:
- Anesthesiologists and Nurse Anesthetists
- Emergency Medicine Physicians
- Critical Care and Intensive Care Unit (ICU) Specialists
- Medical Professionals conducting diagnostic or therapeutic procedures requiring sedation

Supplier Overview:
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Their products and services are used to help care for critically and chronically ill patients. With a robust commitment to quality, innovation, and safety, Fresenius Kabi is a recognized authority in the field of intravenous drugs, including the production of Flumazenil Kabi 0.5mg/5mL Amp 5. Their expertise in pharmaceutical manufacturing and a stringent adherence to regulatory standards ensure that healthcare professionals can trust in the efficacy and safety of their products. Fresenius Kabi's dedication to advancing pharmaceutical care positions them as a leader in the market and a trusted supplier of Flumazenil and other essential medications.